Mutation detection in the human HSP7OB' gene by denaturing high-performance liquid chromatography.

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Genetic variations, such as single nucleotide polymorphisms (SNPs), are crucial for understanding gene function and its relation to disease susceptibility, environmental factors, and therapeutic responses.
• Prostate cancer treatment often involves complex therapies like combined hyperthermia and radiation, necessitating a deeper understanding of the genetic factors influencing patient outcomes.

Purpose of the Study:

• To detect mutations within the HSP70B' gene in human prostate cancer patient biopsy samples.
• To detail the principles and procedures of temperature-modulated heteroduplex analysis (TMHA) for mutation detection using DHPLC technology.
• To characterize the melting behavior of the HSP70B' gene's coding sequence to identify suitable amplicons for mutation analysis.

Main Methods:

• Utilized WAVEMAKER software to predict the melting profile of the HSP70B' gene's complete coding sequence.
• Designed four overlapping amplicons covering the entire coding region, suitable for DHPLC-based mutation detection.
• Performed TMHA on PCR products of individual amplicons using the WAVE Nucleic Acid Fragment Analysis System.

Main Results:

• Identified four overlapping amplicons within the HSP70B' gene amenable to mutation detection via DHPLC.
• Successfully applied TMHA to analyze these amplicons in prostate cancer patient samples.
• Established criteria for mutation calling by comparing wild-type and mutant chromatographic patterns.

Conclusions:

• TMHA, coupled with DHPLC, is an effective method for detecting mutations in the HSP70B' gene.
• The identified amplicons and established criteria facilitate mutation analysis in prostate cancer patients undergoing specific therapies.
• This approach aids in understanding the role of HSP70B' gene variations in prostate cancer and treatment response.